Abstract:ObjectivesProstate cancer (PCa) diagnosis still relies on 12-core systematic biopsy (SBx). More recently, pre-biopsy multiparametric MRI has been introduced in the guidelines as a valuable imaging tool for the detection of significant PCa. However, poor reproducibility and specificity, along with its high cost and limited availability, evidence the need for cost-effective, widespread imaging alternatives. 3D contrast-enhanced ultrasound (CEUS) has shown promise for PCa localization by extraction of quantitative perfusion and dispersion features associated with cancer angiogenesis. Tissue stiffness is an additional PCa biomarker that can be quantified by ultrasound shear-wave elastography (SWE). In this study, the diagnostic potential of multiparametric ultrasound imaging, combining 3D CEUS and SWE features, was evaluated for PCa localization by comparison with the corresponding SBx outcome.MaterialsAfter signing an informed consent, 54 biopsy-naïve patients underwent a 3D CEUS recording using a LOGIQ E9 scanner (GE HealthCare, USA) and a multi-plane (probe sweep) 2D SWE scan using an Aixplorer scanner (SuperSonic Imagine, France) at the Second Affiliated Hospital of Zhejiang University (China). All patients received SBx. Multiple 3D perfusion and dispersion feature maps were extracted from the 3D CEUS acquisitions and further complemented with 3D maps of tissue stiffness, reconstructed based on the multi-plane 2D SWE acquisitions. Subsequently, all the 3D maps were subdivided in 12 regions corresponding to the SBx locations. Gradient Boosting (GB) classification was then implemented together with sequential floating forward feature selection for prediction of the biopsy outcome. The classification accuracy was assessed by a k-fold cross-validation procedure.ResultsOf the 54 patients, 20 had SBx-proven significant PCa. Prediction of biopsy outcome using only CEUS features produced an area under the receiver-operating-characteristic curve (AUC) of 0.81, while using the SWE elasticity alone produced an AUC of 0.66. Their combination yielded an improved AUC of 0.85.ConclusionsThe proposed 3D multiparametric ultrasound imaging approach yields accurate PCa classification results, showing promise for cost-effective PCa localization by multiparametric ultrasound imaging. A multicenter trial has recently started to validate and optimize the classification performance in a larger patient cohort.

Preliminary Study on Ultrasound-Guided Prostate Biopsy Specimen Scores.

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

Current status of prostate biopsy in Chinese Prostate Cancer Consortium member hospitals

Diagnostic Value of Different Systematic Prostate Biopsy Methods in the Detection of Prostate Cancer with Ultrasonographic Hypoechoic Lesions - A Comparative Study

Does PSA level affect the choice of prostate puncture methods among MRI-ultrasound fusion targeted biopsy, transrectal ultrasound systematic biopsy or the combination of both?

Percent Free Prostate-Specific Antigen for Prostate Cancer Diagnosis in Chinese Men with a PSA of 4.0–10.0 Ng/ml: Results from the Chinese Prostate Cancer Consortium

A multicenter retrospective study on evaluation of predicative factors for positive biopsy of prostate cancer in real-world setting

Comprehension of Prostate Puncture Biopsy by Transrectal Ultrasound (report of 658 Cases)

Comparative analysis of PSA and ultrasound-guided biopsy diagnosis of prostate cancer

Clinical analysis of transrectal ultrasound prostate biopsy (reports of 38 cases)

[Establishment of a Scoring System for Predicting the Positive Rate of Prostatic Biopsy for Prostate Cancer].

Evaluation of Transcrectal Ultrasound Guided Biopsies in 189 Prostatic Cancers

Evaluation of the accuracy of biopsy Gleason score as predictors of histological grading of prostate cancer specimens

AB189. Prevalence and risk factors of prostate cancer in Chinese men with PSA 4–10 ng/mL underwent TRUS-guided prostate biopsy: the utilization of PAMD score

Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsies

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 Ng/ml Who Underwent TRUS-Guided Prostate Biopsy: the Utilization of PAMD Score

Systematic Biopsy vs. Prostatectomy: Evaluating Correlations and Grading Discrepancies in Prostate Cancer

Ultrasound Guided Transperineal Prostatic Biopsy for the Diagnosis of Prostatic Cancer

Ratio of initial prostate specific antigen to free prostate specific antigen on diagnosis of prostate carcinoma in Chinese men during post-prostate specific antigen era

Correlation analysis of prostate biopsy and radical prostatectomy specimen

Study of Prostate Specific Antigen Relevant Parameters in Prostate Cancer by Three-Dimensional Transrectal Ultrasonography